Biography

Jim Stefansic is the Senior Director of Corporate Development at Cumberland Emerging Technologies (CET). His responsibilities include sourcing, evaluating, and negotiating for new biopharmaceutical product and technology opportunities especially with academic institutions, in addition to project fundraising and product commercialization.

Dr. Stefansic was previously COO of Pathfinder Therapeutics, Inc., a company he co-founded, where he led FDA regulatory submissions and business development activities. While there, he raised more than $17 million in venture capital and Small Business Innovation Research (SBIR) funding. He also previously served as the Director of Commercialization at Launch Tennessee, where he was instrumental in leading the acquisition of funding to develop and support the statewide SBIR program.  He earned an undergraduate degree in biomedical engineering from Johns Hopkins University, a doctorate from Vanderbilt, and his MBA from Belmont University's Jack C. Massey Graduate School of Business, where he currently serves as President of the Alumni Board of Advisors and was named the Distinguished Alumnus of the Year in 2011. Dr. Stefansic started his career as a Research Assistant Professor at Vanderbilt University Medical Center and has patented several technologies. He also serves as a Director at Raiven Healthcare, an AI analytics company he co-founded and sold to a private equity group.

View LinkedIn